EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Complementation Analysis of Patients with Intact Peroxisomes and Impaired Peroxisomal β-Oxidation

M C McGuinness, A B Moser, B T Poll-The, P A Watkins

Biochemical Medicine and Metabolic Biology · 1993

DOI: 10.1006/bmmb.1993.1025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Medicine and Metabolic Biology, 1993. Verfasst von M C McGuinness und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, NCRR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complementation analysis, using peroxisomal beta-oxidation of very long chain fatty acids (VLCFA) as the criterion for complementation, is useful in the study of patients who are suspected of having a single enzyme defect in the peroxisomal beta-oxidation pathway. Laboratory findings for these patients include elevated plasma VLCFA and impaired VLCFA oxidation in fibroblasts. Some of these patients have slightly abnormal phytanic acid oxidation in fibroblasts. In addition, elevated levels of bile acid intermediates have been reported in some cases. Plasmalogen synthesis, pipecolic acid levels, and subcellular distribution of catalase are normal. Using complementation analysis, we show that six patients, who were suspected of having a single enzyme defect in the peroxisomal beta-oxidation pathway, are deficient in peroxisomal bifunctional enzyme [enoyl-CoA hydratase (EC 4.2.1.17)/3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)] activity. This group of six patients, deficient in bifunctional enzyme activity, may be subdivided into two complementation groups. It would appear that patients in each of these two groups are deficient in only one of the bifunctional enzyme activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

3-Hydroxyacyl CoA DehydrogenasesAdrenoleukodystrophyCell LineEnoyl-CoA HydrataseFatty AcidsHumansImmunoblottingMicrobodiesOxidation-ReductionPhytanic AcidZellweger Syndrome

Substanzen

Fatty AcidsPhytanic Acid3-Hydroxyacyl CoA DehydrogenasesEnoyl-CoA Hydratase

Autor:innen und Institutionen

  • Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Förderung

  • NICHD NIH HHS
  • NCRR NIH HHS

Zitieren

APA

McGuinness, M. C., Moser, A. B., Poll-The, B. T., & Watkins, P. A. (1993). Complementation Analysis of Patients with Intact Peroxisomes and Impaired Peroxisomal β-Oxidation. Biochemical Medicine and Metabolic Biology. https://doi.org/10.1006/bmmb.1993.1025

Vancouver

McGuinness MC, Moser AB, Poll-The BT, Watkins PA. Complementation Analysis of Patients with Intact Peroxisomes and Impaired Peroxisomal β-Oxidation. Biochemical Medicine and Metabolic Biology. 1993. doi:10.1006/bmmb.1993.1025

BibTeX
@article{McGuinness1993,
  author = {McGuinness, M C and Moser, A B and Poll-The, B T and Watkins, P A},
  title = {Complementation Analysis of Patients with Intact Peroxisomes and Impaired Peroxisomal β-Oxidation},
  journal = {Biochemical Medicine and Metabolic Biology},
  year = {1993},
  doi = {10.1006/bmmb.1993.1025}
}
Kostenlos starten →